The funding will allow 52North to move its products, including its Neutrocheck point-of-care device, toward commercialization.
Roche has announced a new 'open innovation ... Near-patient testing (also known as point-of-care testing) is testing taken at the time of the consultation, allowing doctors to make well-informed ...